FDA Person
Center for Drug Evaluation and ResearchDouglas Stearn
View detailed information about Douglas Stearn, including compliance records, violations, and related data.
Person Profile
FDA investigator, Center for Drug Evaluation and Research.
Documents (17)
- WARNING LETTER · Korea Pharma Company Ltd
- WARNING LETTER · C.I. Farmacapsulas S.A. · November 29, 2012
- WARNING LETTER · Orlane S.A. · April 19, 2012
- WARNING LETTER · Zhucheng Haotian Pharm Co., Ltd.
- WARNING LETTER · C.P.M. Contract Pharma GmbH & Co. KG · January 14, 2014
- WARNING LETTER · Changzhou Qianhong Bio-Pharma Co., Ltd · July 9, 2013
- WARNING LETTER · Changzhou Wujin Zhengping Shuangma Chemical Plant
- WARNING LETTER · Pan Drugs Limited
- WARNING LETTER · Quzhou Chemsyn Pharm Co Ltd
- WARNING LETTER · Aurosal Pharmaceuticals Llc · May 24, 2012
- WARNING LETTER · Zhejiang Xianju Chemical Pharmaceutical Factory
- WARNING LETTER · Aino Co., Ltd. of North China Pharmaceutical Group · December 14, 2012
- WARNING LETTER · Peking Medicine Manufactory
- WARNING LETTER · Chinese Peptide Company · May 15, 2012
- WARNING LETTER · Changzhou Jialing Medicine Industry Co Ltd
- WARNING LETTER · Faci S.P.A. · June 14, 2012
- WARNING LETTER · Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd
Related Office
Person Information
Name
Douglas Stearn
Role
Regulatory Personnel
ID: 63f9e646-7970-4dc1-a731-869bbe2cf4be
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.